Skip to main content
. 2022 Jan 6;12:787323. doi: 10.3389/fphys.2021.787323

Table 1.

Experimental design and drug treatments.

Experiment Genotype used Vehicle Drug Dose/Delivery Length of study
HCTZ Control, CA-SPAK, and SPAK KO 35% DMSO diluted in 0.9% saline Hydrochlorothiazide (HCTZ) Sigma 25 mg/kg
IP
4 days
EP1 antagonist CA-SPAK 0.9% saline EP1 antagonist Cayman Chemical SC-51089 6.5 mg/kg
IP
4 days